Canada Regains Market Access for Live Swine to Chile

Jun 15, 2015

Ottawa, Ontario – Agriculture and Agri-Food Canada

The Harper Government has re-established market access to Chile for live swine, a market that industry estimates was worth approximately $350,000 in 2013. Canada had been Chile's main supplier of live swine for over 10 years, prior to 2014 when Chile temporarily suspended imports of live swine and porcine blood products from countries with reported outbreaks of the Porcine Epidemic Diarrhea virus (PEDv), including Canada.

Chile is an important trading partner for Canada and today's announcement is also an example of our commitment to increasing opportunities for Canadian exporters in Latin America, pursuant to Canada's Strategy for Engagement in the Americas and Global Markets Action Plan.

Quick facts

Chile is a priority market under Canada's Global Markets Action Plan with two way merchandise trade reaching $2.86 billion in 2014.
Canadian merchandise exports to Chile in 2014 reached $1.14 billion, an increase of 42 percent over 2013.

Source: AAFC

Video: Intrauterine Vaccines in Swine - Dr. Heather Wilson

In this episode of The Swine it Podcast Show Canada, Dr. Heather Wilson from VIDO at the University of Saskatchewan explains how intrauterine vaccination is being developed as a new option for swine health. She shares how formulation, adjuvants, and delivery methods influence immune responses and what early trials reveal about safety and reproductive performance. Listen now on all major platforms.

"The idea was that an intrauterine vaccine might avoid a tolerance response and instead create an active immune response."

Meet the guest: Dr. Heather Wilson / heather-wilson-a8043641 is a Senior Scientist and Program Manager at the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Her work centers on vaccine formulation and delivery in pigs, including the development of intrauterine vaccination to support reproductive health and passive protection of piglets. Her background spans biochemistry, immunology, and functional pathogenomics.